The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions

被引：0
|
作者：
Li, Xin [1 ]
Cheng, Lin [2 ]
机构：
[1] Xuzhou Med Univ, Dept Orthoped, Affiliated Lianyungang Hosp, Lianyungang, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Orthoped, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China
来源：
OSTEOPOROSIS INTERNATIONAL | 2025年 / 36卷 / 03期
关键词：
D O I：
10.1007/s00198-025-07389-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：573 / 575
页数：3
相关论文
共 50 条
  • [1] Clinical development of anti-RANKL therapy
    Edward M Schwarz
    Christopher T Ritchlin
    Arthritis Research & Therapy, 9
  • [2] Clinical development of anti-RANKL therapy
    Schwarz, Edward M.
    Ritchlin, Christopher T.
    ARTHRITIS RESEARCH & THERAPY, 2007, 9 (Suppl 1)
  • [3] Anti-EGFR Agents: Current Status, Forecasts and Future Directions
    Radoslaw Kwapiszewski
    Sebastian D. Pawlak
    Karolina Adamkiewicz
    Targeted Oncology, 2016, 11 : 739 - 752
  • [4] Anti-EGFR Agents: Current Status, Forecasts and Future Directions
    Kwapiszewski, Radoslaw
    Pawlak, Sebastian D.
    Adamkiewicz, Karolina
    TARGETED ONCOLOGY, 2016, 11 (06) : 739 - 752
  • [5] Raltitrexed: current clinical status and future directions
    Van Cutsem, E
    Cunningham, D
    Maroun, J
    Cervantes, A
    Glimelius, B
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 513 - 522
  • [6] Current status of hemostatic agents, their mechanism of action, and future directions
    Gupta, Ritvesh
    Mohanty, Sibanwita
    Verma, Devendra
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2023, 38 (02) : 77 - 105
  • [7] Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis
    Lipton, Allan
    Goessl, Carsten
    BONE, 2011, 48 (01) : 96 - 99
  • [8] Clinical imaging of hypoxia: Current status and future directions
    Bonnitcha, Paul
    Grieve, Stuart
    Figtree, Gemma
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 126 : 296 - 312
  • [9] Current Status and Future Directions for Clinical Trials Pharmacy
    La, Hyen-Oh
    Choi, Sun
    Lee, Soo-Kyung
    Ryu, Byeung-Eun
    Han, Ok-Yeon
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (06): : 969 - 975
  • [10] EVALUATION OF BONE METABOLISM AND QOL IN PATIENTS WITH OSTEOPOROSIS AFTER TREATMENT WITH THE ANTI-RANKL ANTIBODY DENOSUMAB
    Maeda, T.
    Hayashi, S.
    Miura, Y.
    Sakai, Y.
    Kuroda, R.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S784 - S784
12345